2015 Symposium Sessions

The 2015 Massachusetts Prostate Cancer Coalition Symposium was a fantastic event. Thanks to everyone who participated, presented and sponsored this important event.

If you missed it, you can watch the sessions here. Help us spread this information about prostate cancer by sharing this content with friends, family and colleagues.

Opening Plenary Greetings

Welcome: Mark Kennedy, Executive Director, MPCC
Greetings: Anita Christie, Director, Office of Clinical Prevention Services, Massachusetts Department of Public Health


Opening Keynote:
Understanding and Implementing Immunotherapy for Prostate Cancer

Charles Drake, MD received his Ph.D. in Immunology from the National Jewish Center for Immunology and his MD from the University of Colorado Health Sciences Center. He is currently an associate professor of oncology, urology and immunology at the Johns Hopkins School of Medicine and the co-director of the Prostate Cancer Multidisciplinary Clinic.


Quality of Life After Prostate Cancer: Beyond Erections

Effective treatments for erectile dysfunction and urinary leakage are available to men after treatment for prostate cancer. However, even after these treatments, some men may experience persistent sexual or urinary problems that affect quality of life. We will discuss strategies to overcome problems with orgasm, urinary leakage during intercourse, and overactive bladder.

Ravi Kacker, MD, Men’s Health Boston
Host: William Tinney


Closing Panel:
Prostate Cancer Screening: Emerging Scientific Data and Guidelines

in Collaboration with AdMeTech Foundation

This high level, multidisciplinary panel will discuss the most recent advances in prostate cancer screening. It will begin with a brief history and background on screening and then move into a presentation on guidelines and controversies based on emerging scientific data. Panelists will then engage in a general discussion followed by Q&A from the audience.

Moderator: Faina Shternm, MD – AdMeTech Foundation
Sigrid V. Carlsson, MD, PH.D., MPH – Memorial Sloan-Kettering Cancer Center
J. Jacques Carter, MD – Beth Israel Deaconess Medical Center
Neil E. Martin, MD, MPH – Dana-Farber / Brigham and Women’s Cancer Center
Mark Pomerantz, MD – Dana-Farber Cancer Institute


Closing Remarks

Mark Kennedy, Executive Director, MPCC